In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 756 for your search:
Cancer Type/Condition:  Prostate cancer
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 60 to 90
Sponsor: Other
Protocol IDs: HP 7-251 S, NCT00524823
2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 35 to 90
Sponsor: Other
Protocol IDs: 047838, NCT00805701
3.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: STAF001982HU, NCT00906269
4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: ANG-CP-003, NCT00953277
5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-022, NCT01352598
6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: Thin-1, NCT01379742
7.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB# 11-002288, NCT01365143
8.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: CURC - FIT-0002, NCT01512472
9.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 4-2007-0344, NCT01547416
10.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 90
Sponsor: Other
Protocol IDs: R12038, NCT01571544
11.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: R12-3104L, NCT01581749
12.

Phase: Phase IV
Type: Diagnostic, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ASK-2-2011, NCT01486563
13.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CABAZ_L_06003, U1111-1123-9025, NCT01649635
14.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: UPCC 15810, NCT01661166
15.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A-97-52014-181, 2011-004213-16, NCT01673984
16.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000455008, MRC-STAMPEDE, EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
17.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMT/P2CA/001, LC003AURON2005, NCT00332280
18.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
19.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: MG2009_01, NCT01006395
20.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: S-20090142, NCT01272648
21.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GU004-11, NCT01603420
22.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 18 to 95
Sponsor: Other
Protocol IDs: 1R01CA169188-01, NCT01666808
23.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: RRK4368, 2012-002552-16, NCT01668459
24.

Phase: Phase III
Type: Treatment
Status: Active
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-9346, SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, NCT00002651, PR8
25.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: FCCC-03028, NCT00084552
1     
New Search